http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2593260-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b61159a144b99afb08ba2cf98dcaffbd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-88 |
| filingDate | 2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afbb9b74c6f121015ba50bc903a413b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e1808f4f0939b946b360f985abce8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f9941691bdec2e4911b37049c372ec7 |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2593260-C2 |
| titleOfInvention | Butylphthalide derivative, method for production and use thereof |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: invention relates to a novel compound of formula I, specificaly (S)-(-)-3-(3'-hydroxy)-butylphthalide and an ester formed from a compound of formula I and an acid, which is a pharmaceutically acceptable inorganic or organic acid. Inorganic acid refers to: nitric acid, sulphuric acid or phosphoric acid. In addition to acid radical, organic acid contains at least one amine group, hydroxy group and carboxy group. Neither compound of formula I, nor ester formed therefrom is soluble in water and can be used for treating and preventing cerebral ischemic diseases and improve sleep. Ester obtained from compounds and acid additionally interacts with an acid or base to obtain a salt which is soluble in water and is used to produce injection drug. Experiment showed that salt does not cause irritation of vascular system. n EFFECT: invention also relates to a pharmaceutical composition based on obtained compounds. n 11 cl, 5 tbl, 13 ex |
| priorityDate | 2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.